knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 09:59:01 - browse：66112

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Idaho college killings prosecutors challenge defense's grand jury claims

entertainment

WSS

Aspartame and sugar

CDC advisory group OKs chikungunya vaccine

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Neuroscience renaissance leads to new crop of psychiatric drugs

Idaho college killings prosecutors challenge defense's grand jury claims

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

explore

knowledge

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Redefining sustainability for the pharmaceutical industry

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Indictment alleges Trump's ex

Cancer drug shortages should be causing more outrage

Elisabeth Bik tackles the widespread issue of research misconduct

Alkermes shareholders re

BMS, looking to build heart drug business, turns to AI for diagnosis

As demand for Covid shots wanes, Moderna seeks its next success

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

focus

BMS, looking to build heart drug business, turns to AI for diagnosis

Cholera vaccine supplies dangerously low, outbreaks surging

Mark Cuban is blaming the wrong people for high drug costs

Indictment alleges Trump's ex

After Optum profits sink, UnitedHealth makes changes

Patients, digital health players weigh in on FTC's data privacy plan

explore

entertainment

focus

explore